The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level

被引：0
|
作者：
Sertac Asa
Sabire Yılmaz Aksoy
Betül Vatankulu
Anar Aliyev
Lebriz Uslu
Meftune Ozhan
Sait Sager
Metin Halac
Kerim Sonmezoglu
机构：
[1] University of Istanbul,Department of Nuclear Medicine, Cerrahpasa Medical Faculty
[2] Ataturk Training and Research Hospital,Department of Nuclear Medicine
[3] Kosuyolu Training and Research Hospital,Department of Nuclear Medicine
来源：
Annals of Nuclear Medicine | 2014年 / 28卷
关键词：
FDG-PET/CT; Elevated anti-Tg level; Thyroid cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：970 / 979
页数：9
相关论文
共 50 条
  • [1] The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
    Asa, Sertac
    Aksoy, Sabire Yilmaz
    Vatankulu, Betul
    Aliyev, Anar
    Uslu, Lebriz
    Ozhan, Meftune
    Sager, Sait
    Halac, Metin
    Sonmezoglu, Kerim
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (10) : 970 - 979
  • [2] The clinic role of FDG-PET/CT and Ga68-DOTATATE PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole body scan and elevated serum thyroglobulin level
    Torun, N.
    Erhamamci, S.
    Reyhan, M.
    Nursal, G. N.
    Yapar, A. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S553 - S553
  • [3] Role of F-18 FDG PET/CT in elevated thyroglobulin and negative diagnostic whole body iodine-131 scan in patients with differentiated thyroid cancer
    Mittal, B. R.
    Kashyap, R.
    Bhattacharya, A.
    Singh, B.
    Sood, A.
    Shukla, J.
    Dutta, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S449 - S449
  • [4] Evaluation of iodine-131 therapy for differentiated thyroid carcinoma patients with elevated thyroglobulin and negative iodine-131 whole body scan.
    Tian, R
    Qin, SW
    Kuang, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 334P - 334P
  • [5] The current and evolving role of FDG-PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer
    Pace, Leonardo
    Klain, Michele
    Tagliabue, Luca
    Storto, Giovanni
    CLINICAL AND TRANSLATIONAL IMAGING, 2017, 5 (06) : 533 - 544
  • [6] Guidelines for iodine-131 whole-body scintigraphy in differentiated thyroid cancer
    Dietlein, M
    Dressler, J
    Eschner, W
    Leisner, B
    Reiners, C
    Schicha, H
    NUKLEARMEDIZIN, 1999, 38 (6A) : 213 - 214
  • [7] Iodine-131 whole-body scintigraphy differentiated thyroid carcinoma
    Verburg, Frederik A.
    Gruenwald, Frank
    Lassmann, Michael
    Haenscheid, Heribert
    Luster, Markus
    Dietlein, Markus
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2018, 57 (04): : 124 - 136
  • [8] Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases
    Filesi, M
    Signore, A
    Ventroni, G
    Melacrinis, FF
    Ronga, G
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1542 - 1546
  • [9] The current and evolving role of FDG–PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer
    Leonardo Pace
    Michele Klain
    Luca Tagliabue
    Giovanni Storto
    Clinical and Translational Imaging, 2017, 5 : 533 - 544
  • [10] 18F-FDG-PET scans and high dose of iodine-131 (I-131) treatment in patients with elevated thyroglobulin and negative iodine-131 scan differentiated thyroid carcinoma
    McEwan, Alexander
    Ma, Chao
    Morrish, Donald
    McMullen, Todd
    Capelle, Lisa
    Severin, Diane
    Jha, Naresh
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345